METROmaJX, NCT02630368: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma |
|
|
| Recruiting | 1/2 | 197 | Europe | Cyclophosphamide and JX-594 dose escalation, Brand name : ENDOXAN, Brand name: Pexa-Vec, Cyclophosphamide and JX-594, Cyclophosphamide, Avelumab and JX-594 and Cyclophosphamide, Brand name: ENDOXAN, Brand name: Avelumab | Institut BergoniƩ, National Cancer Institute, France, Fondation ARC, Merck Sharp & Dohme LLC, Transgene | Solid Tumors, Soft-tissue Sarcoma, Breast Cancer | 05/23 | 11/24 | | |